European Commission Approves PADCEV™ (enfortumab vedotin) for Locally Advanced or Metastatic Urothelial Cancer
- Enfortumab vedotin is the first medicine approved in the EU for patients who received…
4 years ago
Wire Stories
Zynga Launches FarmVille 3 in Japan
Latest Expansion to Iconic FarmVille Franchise Released on the Apple App Store and Google Play…
4 years ago
Tech Mahindra Selects Keysight’s Test Solutions to Certify 5G Vendors’ Equipment at its 5G O-RAN Lab in New Jersey, USA
Enabling end-to-end conformance, interoperability and performance validation of open RAN equipment SANTA ROSA, Calif. &…
4 years ago
Uniphore Acquires Colabo to Deliver Knowledge AI and Automation
Knowledge AI capabilities automate extraction of knowledge entities and graphs to empower real-time learning for…
4 years ago
Insights on the Disposable Gloves Global Market to 2031 – by Material, End-use and Region – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Disposable Gloves Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast,…
4 years ago
UserTesting Announces New Capabilities that Provide Organizations with More Customizable and Powerful Machine Learning-Driven Insights
New Fuel Cycle integration enables organizations to capture more context from their known community members…
4 years ago
Blue Foundry Bancorp Schedules First Quarter 2022 Earnings Conference Call
RUTHERFORD, N.J., April 13, 2022 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY) (the “Company”),…
4 years ago
Regarding the supplement of the agenda and proposed draft resolutions of the Ordinary General Meeting of Shareholders of INVL Technology
Special closed-ended type private equity investment company INVL Technology, legal entity code 300893533, the registered…
4 years ago
SES AI Celebrates Its 10th Anniversary
SES AI was founded on April 17th, 2012, originally as SolidEnergy Systems Over the past…
4 years ago
SyneuRx Reaches Target Enrollment in Phase 2 Clinical Trial of COVID-19 Oral Antiviral Candidate Pentarlandir® (SNB01)
Early research suggests Pentarlandir is safe to use against COVID-19; Phase 3 trial evaluating effectiveness…
4 years ago